AI is everywhere, but competitive advantage will belong to leaders who implement it with clarity, patience and purpose.

Why AI’s real failure isn’t intelligence but memory and how broken continuity is quietly undermining advertising performance.

Colgate-Palmolive Q4 2025 earnings call: 2026 outlook, 1%–4% organic sales guide, 2030 strategy, cash flow and risks.

Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of its single-HLA-restricted, genetically unmodified allogeneic T cells. Tevogen ...

From routine jobs to high-value roles, artificial intelligence is reshaping the future of employment and creating new opportunities for skilled professionals ...

Q4 2025 Earnings Call January 30, 2026 8:30 AM ESTCompany ParticipantsJohn Faucher - Chief Investor Relations Officer ...

Tevogen ("Tevogen Bio Holdings Inc." or "Company") (Nasdaq: TVGN) today announced that its Board of Directors has expressed its intention to evaluate the ...

Nathan Sanders, a research affiliate at the Berkman Klein Center for Internet and Society at Harvard University talks about ...

ProMIS Neurosciences Inc. ("ProMIS" or the "Company"), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic misfolded ...

The market expects Frontier Group Holdings (ULCC) to deliver a year-over-year decline in earnings on lower revenues when it ...